A novel injectable water-soluble amphotericin B-arabinogalactan conjugate - Wikidata - wikimedia - TriplyDB

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

http://www.wikidata.org/entity/Q33977425

about

The in vitro characterization of polyene glycosyltransferases AmphDI and NysDI Efficacious treatment of experimental leishmaniasis with amphotericin B-arabinogalactan water-soluble derivatives.Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.Characterization of a Polyethylene Glycol-Amphotericin B Conjugate Loaded with Free AMB for Improved Antifungal Efficacy.In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis.Injectable in situ cross-linking hydrogels for local antifungal therapy.

P2860

Q28294262-C82A026F-9327-48BE-B882-D8364A8EAD35 Q33977623-71A632F4-0709-4323-917F-7ED209B61299 Q34368425-B17B638C-499E-49EE-8E4D-E2B1CC236D30 Q35967724-451A3262-9276-4505-87F1-FA699056CADC Q38325869-2CE4E36E-60C3-424E-A767-961BACD7343B Q39294022-AB615358-C39B-4F08-8797-72E16A438D96 Q39954346-C877A6BD-C45C-46B1-BA26-380DFC558779 Q39955259-513B7E50-C224-402C-A9D7-2154DEAD992E Q42926826-9E4C8066-DC24-4914-B77D-71EE450E1A3C

P2860

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

http://www.wikidata.org/entity/Q33977425

description

1999 nî lūn-bûn

@nan

1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

name

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

@ast

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

@en

type

label

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

@ast

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

@en

prefLabel

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

@ast

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

@en

P1433

Q33977425-96E5F498-3CC4-4D41-BB6F-D843F5B0D48B

P1476

Q33977425-7EC0C866-0B7B-4A94-9631-9DD30EFCDB97

P2093

Q33977425-8D03523E-5883-40A3-86E2-66968B9AE8AD

Q33977425-ED5254BD-FA3C-4430-A945-EE344E12A4A5

Q33977425-F04488AE-366F-4399-8E2C-F0C90D59FF8B

P2860

Q33977425-33C2D5EE-9F7B-4D40-862D-9B7978D62A84

Q33977425-4791BC59-B831-4D63-8786-76C68B08DB78

Q33977425-5A1EAE55-4508-4442-AF03-5639BD730ABC

Q33977425-658DE5CD-1C39-471B-8D1B-66DFA7283FAA

Q33977425-729F4180-C0C6-4458-A8ED-8E9299083151

Q33977425-83EE79F6-1DC9-4424-A39B-A5ABF7F0668B

Q33977425-89440F02-1CFE-41F9-9EA1-3E83505851A2

Q33977425-927B95BB-E288-4E4E-AED6-352FACE8CCCF

Q33977425-9D56337F-30D2-4480-8FB9-21AC2289A891

Q33977425-A1F37E45-D630-49B3-88F0-419538185AD9

P304

Q33977425-446E60FE-8649-4629-8E33-6C4FF9F6E3C3

P31

Q33977425-39E88614-9B23-4235-AA63-6DB52CE8F946

P356

Q33977425-8525F367-0D31-47AB-A2F0-2C5EE9E4BA24

P407

Q33977425-7AE6EB84-DD33-476C-B219-CC693DCDC5B0

P433

Q33977425-FBA0DA74-8E7B-4EEA-838A-DF121DB3E5E2

P478

Q33977425-7C68E4F9-A59D-4BF9-AA54-4534205837FB

P577

Q33977425-498D4CE4-4B66-446F-B47A-2394C635CDB3

P698

Q33977425-C145008B-0BDE-4872-85EB-ECA91A537F9A

P932

Q33977425-C51C076A-9D68-47B2-97FF-4CD00B50C2C6

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

@en

P2093

A J Domb

http://www.w3.org/2001/XMLSchema#string

I Polacheck

http://www.w3.org/2001/XMLSchema#string

R Falk

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.

Amphotericin B: 30 years of clinical experience.

Carrier effects on biological activity of amphotericin B.

Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis.

Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host.

Diagnosis and successful treatment of fusariosis in the compromised host.

Infectious complications in the cancer patient.

Influence of antioxidants on the bioactivity of amphotericin B.

Liposomal amphotericin B, AmBisome.

Overview of amphotericin B colloidal dispersion (amphocil).

P304

1975-1981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.43.8.1975

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10428922

http://www.w3.org/2001/XMLSchema#string

P932

89400

http://www.w3.org/2001/XMLSchema#string